Genitourinary Radiology: Page 6

Swedish MRI study adds momentum to prostate cancer screening
By Kate Madden Yee
A group from the Karolinska in Stockholm has reported that using MRI for prostate cancer screening finds clinically significant cancer and reduces unnecessary biopsies. The team published its results on 9 July in the New England Journal of Medicine.
July 13, 2021
2021 07 13 16 11 0027 Prostate Cancer 400
AI can enhance identification of kidney stones on CT scans
By Erik L. Ridley
Investigators from the University of Turgut Ozal in Malatya, Turkey, have developed an artificial intelligence (AI) algorithm to detect and localize kidney stones on noncontrast CT exams. The algorithm yielded 96.8% accuracy in testing and was deemed to be ready for clinical use.
June 22, 2021
2016 08 23 17 04 30 620 Kidney 400
Groups launch registry to promote SPECT for prostate cancer
By AuntMinnieEurope.com staff writers
The Oncidium Foundation and Telix Pharmaceuticals have launched a registry to promote the use of SPECT with a prostate-specific membrane antigen agent for prostate cancer detection.
April 20, 2021
2016 10 04 11 38 34 158 Prostate 400
Quantib secures CE Mark for prostate MRI software
By AuntMinnieEurope.com staff writers
Artificial intelligence (AI) software developer Quantib has secured the CE Mark for its Quantib Prostate package for prostate MRI interpretation.
April 8, 2021
2016 10 04 11 38 34 158 Prostate 400
Early prostate MRI scans can help reduce mortality rates
By Kate Madden Yee
Researchers from University College London have reported that performing MRI scans before biopsy on men with high prostate-specific antigen scores could cut prostate cancer death rates by as much as 18% versus no screening, while also minimizing the harms of screening.
March 14, 2021
2021 03 15 18 14 1275 Mri Prostate 400
Imaging proves vital when assessing COVID-19 kidney complications
By Kate Madden Yee
Imaging plays a central role in evaluating and tracking kidney complications due to COVID-19 -- and radiologists must not only understand what to look for but also make themselves readily available to their referring colleagues, Italian experts told ECR 2021 attendees.
March 10, 2021
2021 03 11 17 45 5637 2021 03 11 Ecr Renal Covid Image1 20210311171748
Telix secures Czech approval for prostate PET radiopharmaceutical
By AuntMinnieEurope.com staff writers
Telix Pharmaceuticals has received approval from the Czech Republic's Ministry of Health for use of its Illuccix radiopharmaceutical for prostate cancer PET imaging in that country.
February 18, 2021
2021 02 19 01 09 5836 Cancer Cells Prostate 400
French groups issue new guidelines to promote safe contrast use
By Frances Rylands-Monk
French nephrology societies and the national radiology society have published guidelines on the safe use of contrast media in the wake of guidance from the European Society of Urogenital Radiology.
February 14, 2021
2021 02 12 17 02 4497 French Flag Splashes 400
U.K. team backs shorter MRI exam for prostate cancer screening
By Kate Madden Yee
A research team from Imperial College London has reported that a short, biparametric MRI protocol without contrast detected twice as many clinically significant prostate cancers compared with prostate-specific antigen (PSA) testing. The authors published their results on 11 February in JAMA Oncology.
February 14, 2021
2021 02 12 16 33 4471 3 D Prostate Cancer Viral 400
Blue Earth buys therapeutic rights to rhPSMA technology
By AuntMinnieEurope.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics has acquired exclusive, worldwide rights to therapeutic applications of radiohybrid prostate-specific membrane antigen (rhPSMA) technology developed by German radiopharmaceutical firm Scintomics and the Technical University of Munich.
January 4, 2021
2019 12 19 00 53 5252 Hands Shaking Deal 400
Machine learning helps identify cystic renal lesions
By Erik L. Ridley
A machine-learning model based on CT radiomics analysis has achieved excellent diagnostic performance in distinguishing benign from malignant complex cystic renal lesions, outperforming the current Bosniak classification system, Canadian and French investigators reported at the RSNA 2020 meeting.
December 6, 2020
2019 01 15 00 00 8588 Kidneys 400
German group refines PET technique for prostate cancer
By Brian Casey
Researchers from Essen have used a PET-based optical imaging method known as Cerenkov luminescence imaging to highlight the presence of cancer cells after prostate cancer surgery. They published their results in the October edition of the Journal of Nuclear Medicine.
October 12, 2020
2020 10 12 17 13 8441 2020 10 08 Cerenkov 20201012175532
Previous Page
Page 6 of 22
Next Page